Electronic health records can be used to measure and record how guidelines are being implemented and followed, but more government intervention is needed to regulate electronic health records and set standards, Derek Raghavan, MD, PhD, FACP, FRACP, president, Carolinas HealthCare System's Levine Cancer Institute.
Electronic health records can be used to measure and record how guidelines are being implemented and followed, but more government intervention is needed to regulate electronic health records and set standards, Derek Raghavan, MD, PhD, FACP, FRACP, president, Carolinas HealthCare System's Levine Cancer Institute.
Transcript
Once guidelines have been implemented, what strategy should be in place to ensure they are consistently followed?
I think the key is measuring the use of guidelines and the type and patterns of treatment. We now, with all the electronic health records available, have mechanisms to measure what actually happens. Oftentimes, that isn’t done, so it becomes very important for physician leaders, the leader of the pharmacies that supply medications—either to individual practitioners or to group practitioners—to actually work together to measure outcomes, to record outcomes, and to know exactly what is being done.
We’ve had, over the years, a bit of a tendency of what you might call laissez-faire—leaving the people alone, hoping they’ll do the best job they can. And that’s a good implicit concept, but now that we have mechanisms to measure what we’re doing, we need to do that and then to implement those measurements, to understand the results of what we’re doing.
One of the biggest challenges is that so many of the electronic health record systems are so hard to use, they add a lot of working time to the average clinician’s day. And, unfortunately, most of the electronic health records are sold without any measure of government oversight or any requirement for the records to produce what they promise. So, this is going to have to be an area where government gets more actively involved in.
Today, you can sell an electronic health record, as far I know, to anybody. Given that it can have such a big impact on the delivery of healthcare, it’s probably time, in the same way that the physicians and the pharmaceutical industry are being regulated, I think it’s time for the government to start to look at the companies that make electronic health records and set standards of what they need to produce. That, in turn, will allow a much better level of systematization of care.
Award-Winning Poster Presentations From AMCP 2024
April 23rd 2024At the Academy of Managed Care Pharmacy (AMCP) 2024 annual meeting, multiple poster presentations concerned with health equity, data collection, glucagon-like peptide-1 agonists, and more were acknowledged for their originality, relevance, clarity, bias, and quality.
Read More
Emily Goldberg Shares Insights as a Genetic Counselor for Breast Cancer Risk Screening
October 30th 2023On this episode of Managed Care Cast, Emily Goldberg, MS, CGC, a genetic counselor at JScreen, breaks down how genetic screening for breast cancer works and why it is so important to increase awareness and education around these screening tools available to patients who may be at risk for cancer.
Listen
The Importance of Examining and Preventing Atrial Fibrillation
August 29th 2023At this year’s American Society for Preventive Cardiology Congress on CVD Prevention, Emelia J. Benjamin, MD, ScM, delivered the Honorary Fellow Award Lecture, “The Imperative to Focus on the Prevention of Atrial Fibrillation,” as the recipient of this year’s Honorary Fellow of the American Society for Preventive Cardiology award.
Listen
Standard Criteria for Loss of Ambulation Needed in DMD
April 19th 2024A recent study suggests the differences between ambulation definitions for patients with Duchenne muscular dystrophy (DMD) can impact the identification of ambulant vs nonambulant individuals, and standard criteria across settings are needed.
Read More